Supplementation With Omega-3: Mechanism of Action

Stopped early · Phase 2

Conditions studied: Hypertriglyceridemia

In brief

This is a trial of two marketed fish oil supplements, one with a high EPA:DHA ratio and the other with a high DHA:EPA ratio, to examine differential effects on platelet function, blood pressure, and fasting triglyceride levels.

Key facts

Study ID

NCT02036307

Run by

Johns Hopkins University

People needed

13

Starts

2013-04-01

Expected to finish

2015-01-01

Last updated by the study team

2017-03-01

Who can join

Age: 20 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy adults 20-75 years of age.
• Participant of the Principal Investigator's prior studies studies who have agreed to be contacted for future studies.

You may not qualify if…

• Current user of fish oil supplements
• Current user of statins
• Allergy to fish or seafood products
• Diagnosed/treated diabetes mellitus
• Using aspirin or NSAIDS or other "blood-thinning medication"

Where it is running

• Johns Hopkins University — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.